Vivo Capital

United States

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

Founded:1996

Firm Location:United States • Massachusetts • New York, New York • San Francisco, California • Irvine, California • Palo Alto, California • Menlo Park, California • Beijing • Los Altos, California • Hong Kong • Taiwan • Shanghai • San Francisco Bay Area

Vivo Capital Team

INVESTORS	INTRO STRENGTH	SWEET SPOT (RANGE)	INVESTMENT LOCATIONS	TOP INVESTMENT CATEGORIES
Gaurav Aggarwal Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Chen Bian Vivo CapitalAssociate	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA), Investors in Shanghai	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Michael Chang Vivo CapitalPartner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Kevin dai Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +21
Nathan Dau Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +9
DanDan Dong Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Shanghai, Investors in Palo Alto (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +12
Edgar Engleman Vivo CapitalManaging Partner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Frank Kung Vivo CapitalManaging Partner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Xiaoyang li Vivo CapitalAssociate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A) +5
Yixuan Li Vivo CapitalSenior Associate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Marketplaces (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health IT (Series A), Investors in Marketplaces (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Marketplaces (Seed) +13
David Liu Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Taiwan, Investors in Shanghai, Investors in Beijing, Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A) +2
Zhongyi Lu Vivo CapitalPrincipal	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +13
Hongbo Lu Vivo CapitalPartner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Jan Møller Mikkelsen Vivo CapitalAdvisor	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Katera Mujadidi Vivo CapitalPrincipal	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA)	Investors in Consumer Internet (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Seed) +5
Jack Nielsen Vivo CapitalPartner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Fabianne Nordenson Vivo CapitalPrincipal	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed) +8
Daniel Qin Vivo CapitalAssociate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Security (Seed), Investors in Security (Series A), Investors in Marketplaces (Series A), Investors in Marketplaces (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Security (Seed), Investors in Marketplaces (Series A), Investors in Security (Series A), Investors in Marketplaces (Seed) +5
Mahendra Shah Vivo CapitalInvestor	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A) +2
Jo Shen Vivo CapitalVenture Partner	n/a	$25.0M ($10.0M - $50.0M)	Investors in San Francisco (CA)	Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A) +2
Joseph Siletto Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Massachusetts, Investors in San Francisco (CA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +21
Priscilla Sugianto Vivo CapitalSenior Associate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Santa Monica (CA), Investors in United States	Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Seed) +21
Yuh-geng Tsay Vivo CapitalVenture Partner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +17
Jason Wang Vivo CapitalSenior Associate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Menlo Park (CA)	Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Enterprise (Series A), Investors in New York City (Other Lists), Investors in Enterprise (Seed), Investors in Consumer Internet (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Series A), Investors in Consumer Internet (Series A), Investors in Enterprise (Seed) +9
Scott Whitcup Vivo CapitalVenture Partner	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A) +6
Daisy Xu Vivo CapitalManaging Director	n/a	$25.0M ($10.0M - $50.0M)	Investors in Taiwan, Investors in Palo Alto (CA), Investors in Shanghai	Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Medical Devices (Series A) +5
Chloe Zhang Vivo CapitalPrincipal	n/a	$25.0M ($10.0M - $50.0M)	Investors in Beijing, Investors in Shanghai, Investors in Hong Kong, Investors in Taiwan, Investors in Palo Alto (CA)	Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A) +9
Lingfei Zhao Vivo CapitalAssociate	n/a	$25.0M ($10.0M - $50.0M)	Investors in Palo Alto (CA)	Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed) +9